207 related articles for article (PubMed ID: 32659758)
1. Efficacy of Thalidomide in Discoid Lupus Erythematosus: Insights into the Molecular Mechanisms.
Domingo S; Solé C; Moliné T; Ferrer B; Ordi-Ros J; Cortés-Hernández J
Dermatology; 2020; 236(5):467-476. PubMed ID: 32659758
[TBL] [Abstract][Full Text] [Related]
2. [Rediscovery of thalidomide. Successful treatment of discoid lupus erythematosus].
Kuhn A; Hefter H; Ruzicka T; Lehmann P
Hautarzt; 2001 Aug; 52(8):726-33. PubMed ID: 11544946
[TBL] [Abstract][Full Text] [Related]
3. Rapid response to treatment with thalidomide in an adolescent with generalized discoid lupus erythematosus.
Tran B; Yazdani Abyaneh MA; Wu J
Pediatr Dermatol; 2020 Jan; 37(1):244-245. PubMed ID: 31793060
[TBL] [Abstract][Full Text] [Related]
4. Clinical-therapeutic study on the efficacy and safety of thalidomide in the management of discoid lupus erythematosus. A single-centre, retrospective study.
Tirado-Sánchez A; Aguilar-Mena C; Rodriguez-Mendoza A; Hernández-Salgado Y; Bonifaz A
Australas J Dermatol; 2021 Aug; 62(3):375-379. PubMed ID: 33729544
[TBL] [Abstract][Full Text] [Related]
5. Successful long-term thalidomide therapy for discoid lupus erythematosus-lichen planus overlap syndrome.
Zhang L; Au S; Aronson IK
Dermatol Online J; 2014 Oct; 20(10):. PubMed ID: 25526013
[TBL] [Abstract][Full Text] [Related]
6. Clinical and immunologic parameters during thalidomide treatment of lupus erythematosus.
Walchner M; Meurer M; Plewig G; Messer G
Int J Dermatol; 2000 May; 39(5):383-8. PubMed ID: 10849134
[TBL] [Abstract][Full Text] [Related]
7. [Thalidomide therapy for discoid lupus erythematosus].
Lyakhovisky A; Baum S; Shpiro D; Salomon M; Trau H
Harefuah; 2006 Jul; 145(7):489-92, 551. PubMed ID: 16900736
[TBL] [Abstract][Full Text] [Related]
8. Long-term thalidomide use in refractory cutaneous lesions of lupus erythematosus: a 65 series of Brazilian patients.
Coelho A; Souto MI; Cardoso CR; Salgado DR; Schmal TR; Waddington Cruz M; de Souza Papi JA
Lupus; 2005; 14(6):434-9. PubMed ID: 16038106
[TBL] [Abstract][Full Text] [Related]
9. Update on therapy--thalidomide in the treatment of lupus.
Karim MY; Ruiz-Irastorza G; Khamashta MA; Hughes GR
Lupus; 2001; 10(3):188-92. PubMed ID: 11315350
[TBL] [Abstract][Full Text] [Related]
10. Photoprotection by thalidomide in patients with chronic cutaneous and systemic lupus erythematosus: discordant effects on minimal erythema dose and sunburn cell formation.
Cummins DL; Gaspari AA
Br J Dermatol; 2004 Aug; 151(2):458-64. PubMed ID: 15327555
[TBL] [Abstract][Full Text] [Related]
11. Lenalidomide for the treatment of resistant discoid lupus erythematosus.
Shah A; Albrecht J; Bonilla-Martinez Z; Okawa J; Rose M; Rosenbach M; Werth VP
Arch Dermatol; 2009 Mar; 145(3):303-6. PubMed ID: 19289762
[TBL] [Abstract][Full Text] [Related]
12. [Thalidomide and thrombosis].
Flageul B; Wallach D; Cavelier-Balloy B; Bachelez H; Carsuzaa F; Dubertret L
Ann Dermatol Venereol; 2000 Feb; 127(2):171-4. PubMed ID: 10739975
[TBL] [Abstract][Full Text] [Related]
13. Microarray study reveals a transforming growth factor-β-dependent mechanism of fibrosis in discoid lupus erythematosus.
Solé C; Gimenez-Barcons M; Ferrer B; Ordi-Ros J; Cortés-Hernández J
Br J Dermatol; 2016 Aug; 175(2):302-13. PubMed ID: 26972571
[TBL] [Abstract][Full Text] [Related]
14. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
[TBL] [Abstract][Full Text] [Related]
15. Acitretin treatment in antimalarial-refractory/intolerant discoid lupus erythematosus: A prospective, open-label, uncontrolled study.
Laosakul K; Chiewchanvit S; Chuamanochan M; Tovanabutra N
Lupus; 2022 Apr; 31(5):575-581. PubMed ID: 35306922
[TBL] [Abstract][Full Text] [Related]
16. Thalidomide and discoid lupus erythematosus: case series and review of literature.
Malara G; Verduci C; Altomonte M; Cuzzola M; Trifirò C; Politi C; Tripepi G
Drugs Context; 2022; 11():. PubMed ID: 35371272
[TBL] [Abstract][Full Text] [Related]
17. Rapamycin for refractory discoid lupus erythematosus.
Herold M; Richmond NA; Montuno MA; Wesson SK; Motaparthi K
Dermatol Ther; 2018 Sep; 31(5):e12631. PubMed ID: 30109759
[TBL] [Abstract][Full Text] [Related]
18. [Thalidomide in the treatment of chronic discoid lupus erythematosus].
Brocard A; Barbarot S; Milpied B; Stalder JF
Ann Dermatol Venereol; 2005 Nov; 132(11 Pt 1):853-6. PubMed ID: 16327714
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment with topical tacrolimus in four cases of discoid lupus erythematosus.
Sugano M; Shintani Y; Kobayashi K; Sakakibara N; Isomura I; Morita A
J Dermatol; 2006 Dec; 33(12):887-91. PubMed ID: 17169097
[TBL] [Abstract][Full Text] [Related]
20. Apremilast for discoid lupus erythematosus: results of a phase 2, open-label, single-arm, pilot study.
De Souza A; Strober BE; Merola JF; Oliver S; Franks AG
J Drugs Dermatol; 2012 Oct; 11(10):1224-6. PubMed ID: 23134988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
